1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Massachusetts >
  6. Millendo Therapeutics Acquires OvaScience

M&A Deal Summary

Millendo Therapeutics Acquires OvaScience

On November 1, 2018, Millendo Therapeutics acquired life science company OvaScience

Acquisition Highlights
  • This is Millendo Therapeutics’ 2nd transaction in the Life Science sector.
  • This is Millendo Therapeutics’ 1st transaction in the United States.
  • This is Millendo Therapeutics’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2018-11-01
Target OvaScience
Sector Life Science
Buyer(s) Millendo Therapeutics
Deal Type Merger
Advisor(s) Ladenburg Thalmann & Co. (Financial)
Mintz Levin Cohn Ferris Glovsky and Popeo (Legal)

Target

OvaScience

Waltham, Massachusetts, United States
OvaScience, Inc. is a life sciences company dedicated to improving fertility for women. OvaScience was founded in 2011 and is based in Waltham, Massachusetts.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Millendo Therapeutics

Ann Arbor, Michigan, United States
Category Company
Sector Life Science
DESCRIPTION

Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Millendo Therapeutics creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. Millendo Therapeutics is based in Ann Arbor, Michigan.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Merger M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-12-20 Alizé Pharma SAS

Ecully, France

Alizé Pharma SAS is a designer and developer of livoletide. Alizé Pharma was founded in 2007 and is based in Ecully, France.

Buy -
Mergr

Solution for

Product

Company

Legal